Cerus (CERS) FCF Margin Growth (3y) (2013 - 2026)
Cerus (CERS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 2,679.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -461.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 417.00 |
| 10 | Cerus | 505.74 Mn | 426.05 Mn | 27.89 Mn | 6,534.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,534.00 |
| Dec 31, 2025 | 630.00 |
| Sep 30, 2025 | 69,870.00 |
| Jun 30, 2025 | -3,520.00 |
| Mar 31, 2025 | 14,351.00 |
| Dec 31, 2024 | 698.00 |
| Sep 30, 2024 | 223,048.00 |
| Jun 30, 2024 | 143,744.00 |
| Mar 31, 2024 | 404,632.00 |
| Dec 31, 2023 | 186.00 |
| Sep 30, 2023 | 6,426.00 |
| Jun 30, 2023 | -96,252.00 |
| Mar 31, 2023 | 9,429.00 |
| Dec 31, 2022 | 3,897.00 |
| Sep 30, 2022 | -56,406.00 |
| Jun 30, 2022 | 8,549.00 |
| Mar 31, 2022 | 5,576.00 |
| Dec 31, 2021 | 4,461.00 |
| Sep 30, 2021 | -218,830.00 |
| Jun 30, 2021 | -121,186.00 |